Akèy › Kansè (tout kalite) › Vermont
Etid klinik pou Kansè (tout kalite) nan Vermont
7 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan Vermont.
Vil nan Vermont
Tèks ofisyèl etid la (Anglè)
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- White River Junction Veterans Healthcare System, White River Junction
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05796375A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- The University of Vermont Medical Center Inc., Burlington
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581Project: Every Child for Younger Patients With Cancer
- University of Vermont and State Agricultural College, Burlington
Ap rekriteEtid obsèvasyon
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
- University of Vermont Cancer Center, Burlington
Ap rekriteVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Aug 10, 2026 · NCT07061652Care Coordination Educational Intervention Study for Patients From Rural Areas With Early Stage Cancer
- University of Vermont Cancer Center, Burlington
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT05723250DOAC - Dosing Options in AntiCoagulation Prophylaxis
- University of Vermont Medical Center, Burlington
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT07005024Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of Vermont Medical Center, Burlington
- University of Vermount and Sate Agricultural College, Burlington
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Nov 27, 2024 · NCT03860883Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.